ALAMAR BIOSCIENCES, INC.

Ajouter à une liste

Communiqués Alamar Biosciences, Inc.

Actions

ALMR

US0109111056

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq 22:00:00 29/09/2026			Varia. 5j.	Varia. 1 janv.
32,65 ^USD	+0,12 %		-1,72 %	-

25/09	Alamar Biosciences, Inc. annonce la publication dans The Lancet Neurology de la première étude de cohorte longitudinale	CI
16/09	Transcript : Alamar Biosciences, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 04:05 PM

Communiqués

25/09	Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment	GL
01/09	Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference	GL
11/08	Alamar Biosciences Expands Global Partnership with Alzheimer's Disease Data Initiative and Gates Ventures	AQ
10/08	Alamar: Q2 Earnings Snapshot	AQ
10/08	Alamar Biosciences Reports Second Quarter 2026 Financial Results and Provides 2026 Revenue Guidance	GL
10/08	Alamar Biosciences Expands Global Partnership with Alzheimer’s Disease Data Initiative and Gates Ventures	GL
10/08	Alamar Biosciences Expands Global Partnership with Alzheimer’s Disease Data Initiative and Gates Ventures	AQ
28/07	Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome	GL
28/07	Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome	GL
14/07	Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026	GL
13/07	Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases	GL
10/07	Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling	GL
07/07	Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research	GL
08/05	Alamar Biosciences Reports First Quarter 2026 Financial Results	GL
05/05	Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Articles Zonebourse Analyses Zonebourse

Filtres

Les meilleurs outils réservés aux abonnés pour augmenter la performance de vos investissements !

🔇